First Wave BioPharma Shares Jump 21% on FDA Review of Adrulipase IND Filing

Retrieved on: 2023-01-13 21:13:11

Tags for this article:

Click the tags to see associated articles and topics

First Wave BioPharma Shares Jump 21% on FDA Review of Adrulipase IND Filing. View article details on hiswai:

Excerpt

By Denny Jacob First Wave BioPharma Inc. shares jumped 21% to 79 cents in after-hours trading Friday following news that the Food and Drug ...

Article found on: www.marketwatch.com